Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

  • Exchange: NASDAQ GS
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Biotech

Regeneron Pharmaceuticals Inc

+ Add to Watchlist


513.810 USD 1.250 0.24%

As of 20:10:00 ET on 06/01/2015.

Company Profile for Regeneron Pharmaceuticals Inc (REGN)

Regeneron Pharmaceuticals, Inc. is a biopharmaceutical company that discovers, develops, and commercializes pharmaceutical products for the treatment of serious medical conditions. The Company has therapeutic candidates in clinical trials for the potential treatment of cancer, eye diseases, and inflammatory diseases, and has preclinical programs in other diseases and disorders.

Contact Information

Regeneron Pharmaceuticals Inc

777 Old Saw Mill River Road
Tarrytown, NY 10591-6707
United States
Phone: 1-914-847-7000
Fax: 1-914-347-2847

Key Executives for Regeneron Pharmaceuticals Inc (REGN)

Leonard S Schleifer "Len"President/CEO/Co-FounderGeorge D YancopoulosPres:Laboratories
Neil StahlExec VP:Research & DevelopmentJoseph J Larosa "Joe"Senior VP/Secy/General Counsel
Daniel P Van PlewSenior VP/Gen Mgr:Industrial OpsRobert E Landry Jr "Bob"Senior VP:Finance/CFO
Robert J TerifaySenior VP:CommercialPeter PowchikSenior VP:Clinical Development
Michael AbermanSenior VP:Strategy & IRDouglas S McCorkleVP/Asst Treasurer/Controller

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

sec ||= nil